Security key
413197104
Harmony Biosciences Holdings, Inc. - Common Stock (HRMY)
CUSIP: 413197104
Q4 2021 13F Holders as of 31 Dec 2021
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 57,644,670
- Total 13F shares
- 44,541,354
- Share change
- +2,463,581
- Total reported value
- $1,899,444,678
- Price per share
- $42.64
- Number of holders
- 138
- Value change
- +$107,131,256
- Number of buys
- 90
- Number of sells
- 42
Report period
Q4 2021
Institutions
138
Top holders
10
HRMY full security history
Newer quarter: Q1 2022
Previous quarter: Q3 2021
Harmony Biosciences Holdings, Inc. SEC filings
Harmony Biosciences Holdings, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 413197104
Recent filing periods:
Top shareholders of HRMY - Harmony Biosciences Holdings, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Vivo Capital, LLC |
13F
|
Company |
8.5%
|
4,884,341
|
$187,217,000 | — | 30 Sep 2021 | |
| FMR LLC |
13F
|
Company |
7.2%
|
4,128,951
|
$158,263,000 | — | 30 Sep 2021 | |
| VANGUARD GROUP INC |
13F
|
Company |
5.4%
|
3,099,941
|
$118,820,000 | — | 30 Sep 2021 | |
| venBio Partners LLC |
13F
|
Company |
5.3%
|
3,063,194
|
$117,412,000 | — | 30 Sep 2021 | |
| Newlight Partners LP |
13F
|
Company |
3.3%
|
1,900,824
|
$72,859,000 | — | 30 Sep 2021 | |
| BlackRock Finance, Inc. |
13F
|
Company |
2.8%
|
1,614,173
|
$61,873,000 | — | 30 Sep 2021 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
2.2%
|
1,240,415
|
$47,545,000 | — | 30 Sep 2021 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
2.1%
|
1,219,559
|
$46,746,000 | — | 30 Sep 2021 | |
| Blackstone Inc. |
13F
|
Company |
1.8%
|
1,048,951
|
$40,206,000 | — | 30 Sep 2021 | |
| Nan Fung Group Holdings Ltd |
13F
|
Company |
1.3%
|
768,708
|
$29,465,000 | — | 30 Sep 2021 | |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ |
13F
|
Company |
1.2%
|
667,784
|
$25,596,000 | — | 30 Sep 2021 | |
| ASHFORD CAPITAL MANAGEMENT INC |
13F
|
Company |
1.1%
|
630,473
|
$24,166,000 | — | 30 Sep 2021 | |
| Aisling Capital Management LP |
13F
|
Company |
1%
|
592,815
|
$22,723,000 | — | 30 Sep 2021 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
0.85%
|
491,332
|
$18,833,000 | — | 30 Sep 2021 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.8%
|
461,266
|
$17,680,000 | — | 30 Sep 2021 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.71%
|
411,110
|
$15,757,000 | — | 30 Sep 2021 | |
| STATE STREET CORP |
13F
|
Company |
0.69%
|
396,858
|
$15,212,000 | — | 30 Sep 2021 | |
| ROTHSCHILD & CO ASSET MANAGEMENT US INC. |
13F
|
Company |
0.52%
|
300,019
|
$11,500,000 | — | 30 Sep 2021 | |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC |
13F
|
Company |
0.41%
|
236,000
|
$9,020,000 | — | 30 Sep 2021 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.4%
|
232,029
|
$8,894,000 | — | 30 Sep 2021 | |
| ROYCE & ASSOCIATES LP |
13F
|
Company |
0.4%
|
229,390
|
$8,793,000 | — | 30 Sep 2021 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.37%
|
212,308
|
$8,138,000 | — | 30 Sep 2021 | |
| Rhenman & Partners Asset Management AB |
13F
|
Company |
0.36%
|
204,876
|
$7,853,000 | — | 30 Sep 2021 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.33%
|
188,811
|
$7,237,000 | — | 30 Sep 2021 | |
| Atle Fund Management AB |
13F
|
Company |
0.32%
|
185,000
|
$7,091,000 | — | 30 Sep 2021 | |
| MPM BioImpact LLC |
13F
|
Company |
0.26%
|
151,650
|
$5,813,000 | — | 30 Sep 2021 | |
| RICE HALL JAMES & ASSOCIATES, LLC |
13F
|
Company |
0.24%
|
139,214
|
$5,336,000 | — | 30 Sep 2021 | |
| Bellevue Group AG |
13F
|
Company |
0.22%
|
129,289
|
$4,956,000 | — | 30 Sep 2021 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
0.21%
|
123,600
|
$4,738,000 | — | 30 Sep 2021 | |
| ADVISORY RESEARCH INC |
13F
|
Company |
0.21%
|
119,050
|
$4,563,000 | — | 30 Sep 2021 | |
| COMERICA BANK |
13F
|
Company |
0.17%
|
96,340
|
$3,934,000 | — | 30 Sep 2021 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
0.18%
|
102,292
|
$3,921,000 | — | 30 Sep 2021 | |
| LMR Partners LLP |
13F
|
Company |
0.17%
|
100,000
|
$3,833,000 | — | 30 Sep 2021 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.16%
|
91,376
|
$3,502,000 | — | 30 Sep 2021 | |
| ExodusPoint Capital Management, LP |
13F
|
Company |
0.15%
|
87,716
|
$3,362,000 | — | 30 Sep 2021 | |
| CAMBIAR INVESTORS LLC |
13F
|
Company |
0.14%
|
82,222
|
$3,152,000 | — | 30 Sep 2021 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.14%
|
82,144
|
$3,148,000 | — | 30 Sep 2021 | |
| Ghost Tree Capital, LLC |
13F
|
Company |
0.13%
|
75,000
|
$2,875,000 | — | 30 Sep 2021 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.12%
|
68,553
|
$2,628,000 | — | 30 Sep 2021 | |
| SEI INVESTMENTS CO |
13F
|
Company |
0.11%
|
63,718
|
$2,442,000 | — | 30 Sep 2021 | |
| CIBC Private Wealth Group LLC |
13F
|
Company |
0.1%
|
60,000
|
$2,300,000 | — | 30 Sep 2021 | |
| Cubist Systematic Strategies, LLC |
13F
|
Company |
0.09%
|
54,633
|
$2,094,000 | — | 30 Sep 2021 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.09%
|
54,516
|
$2,090,000 | — | 30 Sep 2021 | |
| Jump Financial, LLC |
13F
|
Company |
0.09%
|
54,430
|
$2,087,000 | — | 30 Sep 2021 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.09%
|
53,662
|
$2,057,000 | — | 30 Sep 2021 | |
| MORGAN STANLEY |
13F
|
Company |
0.08%
|
44,484
|
$1,706,000 | — | 30 Sep 2021 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.07%
|
41,047
|
$1,574,000 | — | 30 Sep 2021 | |
| Novo Holdings A/S |
13F
|
Company |
0.07%
|
40,000
|
$1,533,000 | — | 30 Sep 2021 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.07%
|
39,400
|
$1,510,000 | — | 30 Sep 2021 | |
| Swiss National Bank |
13F
|
Company |
0.07%
|
37,600
|
$1,441,000 | — | 30 Sep 2021 |
Institutional Holders of Harmony Biosciences Holdings, Inc. - Common Stock (HRMY) as of Q4 2021
As of 31 Dec 2021,
Harmony Biosciences Holdings, Inc. - Common Stock (HRMY) was held by
138 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
44,541,354 shares.
The largest 10 holders included
Valor Management LLC, Vivo Capital, LLC, FMR LLC, BlackRock Inc., venBio Partners LLC, VANGUARD GROUP INC, ADAGE CAPITAL PARTNERS GP, L.L.C., JANUS HENDERSON GROUP PLC, Blackstone Inc, and Newlight Partners LP.
This page lists
139
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2021 vs Q3 2021 Across Filers
Q3 2021 holders
99
Q4 2021 holders
138
Holder diff
39
| Investor | Q3 2021 Shares | Q4 2021 Shares | Share Diff | Share Chg % | Q3 2021 Value $ | Q4 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.